Raymond James & Associates’s BlackRock Health Sciences Trust II BMEZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $8.06M | Buy |
508,606
+123
| +0% | +$1.95K | ﹤0.01% | 1350 |
|
|
2024
Q2 | $7.81M | Sell |
508,483
-1,713
| -0.3% | -$26.3K | 0.01% | 1309 |
|
|
2024
Q1 | $8.36M | Sell |
510,196
-5,765
| -1% | -$94.5K | 0.01% | 1262 |
|
|
2023
Q4 | $7.56M | Sell |
515,961
-35,673
| -6% | -$523K | 0.01% | 1277 |
|
|
2023
Q3 | $7.95M | Sell |
551,634
-227,181
| -29% | -$3.27M | 0.01% | 1175 |
|
|
2023
Q2 | $12.8M | Sell |
778,815
-22,385
| -3% | -$368K | 0.01% | 916 |
|
|
2023
Q1 | $13.4M | Sell |
801,200
-43,710
| -5% | -$730K | 0.01% | 869 |
|
|
2022
Q4 | $13M | Sell |
844,910
-105,887
| -11% | -$1.63M | 0.01% | 861 |
|
|
2022
Q3 | $14.2M | Sell |
950,797
-204,582
| -18% | -$3.05M | 0.01% | 770 |
|
|
2022
Q2 | $19M | Buy |
1,155,379
+115,958
| +11% | +$1.91M | 0.02% | 635 |
|
|
2022
Q1 | $20.9M | Buy |
1,039,421
+230,216
| +28% | +$4.62M | 0.02% | 679 |
|
|
2021
Q4 | $20.5M | Sell |
809,205
-64,421
| -7% | -$1.63M | 0.02% | 732 |
|
|
2021
Q3 | $23.6M | Sell |
873,626
-7,513
| -0.9% | -$203K | 0.02% | 619 |
|
|
2021
Q2 | $25.5M | Buy |
881,139
+8,606
| +1% | +$249K | 0.02% | 593 |
|
|
2021
Q1 | $22.9M | Buy |
872,533
+223,818
| +35% | +$5.89M | 0.02% | 604 |
|
|
2020
Q4 | $18.6M | Sell |
648,715
-11,775
| -2% | -$337K | 0.02% | 650 |
|
|
2020
Q3 | $15.8M | Buy |
660,490
+39,861
| +6% | +$951K | 0.02% | 641 |
|
|
2020
Q2 | $13M | Buy |
620,629
+50,414
| +9% | +$1.05M | 0.02% | 696 |
|
|
2020
Q1 | $10.2M | Buy |
+570,215
| New | +$10.2M | 0.02% | 741 |
|